about
Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgeryCurrent perspectives on primary prophylaxis and patient risk factors for venous thromboembolism in the cancer patient.Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.New oral anticoagulants in the treatment of pulmonary embolism: efficacy, bleeding risk, and monitoring.Incidence of hospital readmission in patients diagnosed with DVT and PE: clinical burden of recurrent events.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacoeconomics of thrombosis management.
@ast
Pharmacoeconomics of thrombosis management.
@en
type
label
Pharmacoeconomics of thrombosis management.
@ast
Pharmacoeconomics of thrombosis management.
@en
prefLabel
Pharmacoeconomics of thrombosis management.
@ast
Pharmacoeconomics of thrombosis management.
@en
P2860
P1433
P1476
Pharmacoeconomics of thrombosis management.
@en
P2093
David Hawkins
P2860
P304
P356
10.1592/PHCO.24.10.95S.36123
P407
P433
P577
2004-07-01T00:00:00Z